key: cord-0934149-w4qks1o1 authors: Hawkes, Michael T.; Lee, Bonita E.; Kanji, Jamil N.; Zelyas, Nathan; Wong, Kerry; Barton, Michelle; Mukhi, Shamir; Robinson, Joan L. title: Seasonality of Respiratory Viruses at Northern Latitudes date: 2021-09-16 journal: JAMA Netw Open DOI: 10.1001/jamanetworkopen.2021.24650 sha: ca22e968bed2dca871117551b90cbcaa94f9656f doc_id: 934149 cord_uid: w4qks1o1 IMPORTANCE: Every year, respiratory viruses exact a heavy burden on Canadian hospitals during winter months. Generalizable seasonal patterns of respiratory virus transmission may estimate the evolution of SARS-CoV-2 or other emerging pathogens. OBJECTIVE: To describe the annual and biennial variation in respiratory virus seasonality in a northern climate. DESIGN, SETTING, AND PARTICIPANTS: This cohort study is an epidemiological assessment using population-based surveillance of patients with medically attended respiratory tract infection from 2005 through 2017 in Alberta, Canada. Incident cases of respiratory virus infection and infant respiratory syncytial virus (RSV) hospitalizations in Alberta were extracted from the Data Integration for Alberta Laboratories platform and Alberta Health Services Discharge Abstract Database, respectively. A deterministic susceptible-infected-recovered-susceptible mathematical model with seasonal forcing function was fitted to the data for each virus. The possible future seasonal course of SARS-CoV-2 in northern latitudes was modeled on the basis of these observations. The analysis was conducted between December 15, 2020, and February 10, 2021. EXPOSURES: Seasonal respiratory pathogens. MAIN OUTCOMES AND MEASURES: Incidence (temporal pattern) of respiratory virus infections and RSV hospitalizations. RESULTS: A total of 37 719 incident infections with RSV, human metapneumovirus, or human coronaviruses 229E, NL63, OC43, or HKU1 among 35 375 patients (18 069 [51.1%] male; median [interquartile range], 1.29 [0.42-12.2] years) were documented. A susceptible-infected-recovered-susceptible model mirrored the epidemiological data, including a striking biennial variation with alternating severe and mild winter peaks. Qualitative description of the model and numerical simulations showed that strong seasonal contact rate and temporary immunity lasting 6 to 12 months were sufficient to explain biennial seasonality in these various respiratory viruses. The seasonality of 10 212 hospitalizations among children younger than 5 years with RSV was also explored. The median (interquartile range) rate of hospitalizations per 1000 live births was 18.6 (17.6-19.9) and 11.0 (10.4-11.7) in alternating even (severe) and odd (less-severe) seasons, respectively (P = .001). The hazard of admission was higher for children born in severe (even) seasons compared with those born in less-severe (odd) seasons (hazard ratio, 1.68; 95% CI, 1.61-1.75; P < .001). CONCLUSIONS AND RELEVANCE: In this modeling study of respiratory viruses in Alberta, Canada, the seasonality followed a pattern estimated by simple mathematical models, which may be informative for anticipating future waves of pandemic SARS-CoV-2. RSV infection is nearly ubiquitous in infancy, and most children are infected by the age of 2 years (1). In Alberta, approximately 1.6% of children have one or more RSV hospitalizations before the age of 5 years, with most infections occurring in the first year of life (2) . RSV shows striking seasonality, which is accentuated in northern latitudes (3) . In temperate zones, most RSV cases occur in the cold season and in tropical zones, most cases occur in the wet season (4) . The mean duration of viral shedding is 6.7 days (range 1-21) (5) . Re-infection is common, with annual re-infection rates of 20%, 17%, 10%, and 3-6% among children 5-9, 10-14, 15-19 years of age, and adults, respectively (6) . Immunity wanes over time, as demonstrated experimentally in adults with previous natural immunity to RSV re-challenged with a homologous RSV strain. By 2 months after natural RSV infection, 50% of healthy adults became re-infected, and by 8 months, two thirds became re-infected (7) . Within 26 months, 76% had two or more infections and 47% had three or more infections (7) . Most RSV infections are mild, even in young infants. The rate of hospitalization among infected infants is 1.6 to 3.3% (1, 8) . Nearly all individuals are infected with hMPV early in life. One quarter of Dutch children between 6 and 12 months of age and nearly all five-year-old children had antibodies to hMPV (9) . Similarly, in a Japanese cohort, 77% and 100% of children 2 to 5 and >10 years of age had hMPV antibodies, respectively (10) . In a study from Thailand, 99.7% of children 6-16 years old had positive hMPV serology (11) . Four genetic subgroups of hMPV (A1, A2, © 2021 Hawkes MT et al. JAMA Network Open. B1, and B2) are recognized, with variable incidence from year to year (12) . They are antigenically similar and induce a variable cross-neutralizing antibody response (12, 13) . Reinfection occurs throughout childhood. In Thailand, 5% of children had evidence of reinfection over a four-year period, as defined by a 4-fold rise in immunoglobulin titres. Many children with acute hMPV exhibit both a positive IgM and IgG at presentation, followed by a 4-fold rise in IgG, indicating that they were previously infected, but that circulating IgG does not confer complete immunity (10) . In non-human primate models, antibodies can mediate protection but titers wane over time (14) . Taken together, these results suggest that transient protective immunity to hMPV allows recurrent infection over the lifetime of an individual. Seasonality of hMPV is well documented in temperate zones. A biennial pattern has been described previously, with strong peaks of activity in late spring-summer months every second year (15) . The duration of viral shedding was 5.6 days after experimental challenge with HCoV 229E in healthy volunteers (16) . Infection with HCoVs does not confer long-lasting sterile immunity. In a hospital-and community-based study of three coronaviruses (HCoV NL-63, OC-43, or 229E) among Kenyan children, 4-21% had documented re-infection within 47 and 98 days of the initial episode (17) . In a serologic study from the Netherlands, ten healthy adults followed for 35 years experienced 101 infections (3 to 17 per individual) with HCoV NL-63, 229E, OC43, or HKU1, often repeatedly with the same strain (18) . In an experimental challenge model with HCoV 229E in 15 healthy volunteers, 10 were infected, 8 were symptomatic, and 6 were infected a second time with repeat challenge 12 months later, although none of the second infections were symptomatic and the duration of viral shedding was reduced (16) . Natural immunity to other severe and epidemic coronaviruses, SARS-CoV and MERS-CoV, has not been reported. On the other hand, short-lived immunity and associated antibody responses are well documented. Volunteers resistant to initial HCoV 229E challenge had significantly higher levels of specific serum IgG and nasal IgA, suggesting that prior natural infection conferred temporary immunity (16) . Although the precise duration of immunity is not known, these same volunteers were susceptible to re-infection after a period of 12 months (16) . In another study, antibodies levels following natural infection decayed by 50% and 75% within 6 and 12 months of infection, respectively (18) . In another modelling study, immunity to HCoV OC43 and HKU1 lasted approximately 45 weeks (19) . The basic reproduction number (R0) for SARS-CoV-2 (average number of new infections per infected at the beginning of the epidemic), has been estimated to be around R0 = 2 -3 (2.2 with 90% high density interval 1.4-3.8 (20) or 2.7 with a 95% CrI of 2.47-2.86 (21) . Whether temporary or longer-term immunity to SARS-CoV-2 exists is unknown, but has important implications for natural and vaccine-induced immunity. Using a non-human primate model, resistance to re-infection with SARS-CoV-2 has been demonstrated one month after initial infection, with associated SARS-CoV-2-specific memory B-cells (22) . PCR positivity in patients with COVID-19 can return following repeated negative results (23, 24); however, the relatively short period before repeat positivity suggests they may not have cleared the initial infection. Reinfection with SARS-CoV-2 several months after clearing an initial infection has been reported (25). It is thus too early to say whether natural immunity to SARS-CoV-2 will contribute to herd immunity. The dependent (time-to-event) variable was the interval from birth to the age at first RSV admission. The independent variables were the month of the year (e.g., January, coded as a 12-level categorical variable) and the RSV season (even or odd, coded as a binary variable). Members of the birth cohort who were not hospitalized for RSV were censored at age 5 years. To simplify the qualitative analysis, we assumed that the birth rate and death rate were equal, such that the population was of constant size. Without loss of generality, we assumed a population size N=1, such that S, I and R were interpreted as proportions of the total population. The SIRS model has two stationary solutions: a disease free equilibrium (DFE): The following race analogy has been used to explain the model's solution (27) . The trajectory can be thought of as a hopeless 'pursuer' in a race to catch the EE, which plays the role of the fast 'leader' that cannot be caught (27) . While ℛ 0 ( ) > 1, the leader is deemed as stable EE. As soon as ℛ 0 ( ) < 1, the leader is deemed unstable and the solution's trajectory pursues the DFE. At that moment, the trajectory 'switches its objective,' pursues the DFE instead of the EE, and continues to do so while ℛ 0 ( ) < 1. The sudden change of objective gives rise to a period doubling bifurcation of the limit cycle (eFigure 1). Under what conditions will the stable limit cycle demonstrate a biennial pattern? We varied key model parameters 1 and and determined the peak infected fraction (eFigure 3). As predicted by the bifurcation analysis, a biennial pattern emerged for 1 > 1 − (<160 days) results in rapid decay of the recovered (immune) fraction before the onset of the next season. On the other hand, long-lasting immunity (>380 days) results in the accumulation of the recovered (immune) fraction over multiple years. When immunity wanes on the order of 1 year, a severe season results in a marked wave of infected individuals who enter the recovered (immune) fraction at a time coinciding with the following seasonal peak. The large fraction recovered (immune) individuals blunts the seasonal peak, generating the observed biennial pattern. In summary, the following conditions were associated with a biennial seasonal pattern (numerical values were computed from plausible model parameters): (1) The basic reproduction number of the model without seasonality must be greater than unity, in order for a non-zero stable endemic equilibrium to exist. (2) The seasonal variation must generate a period doubling bifurcation. Risk of primary infection and reinfection with respiratory syncytial virus Risk of Repeated Admissions for Respiratory Syncytial Virus in a Cohort of >10 000 Hospitalized Children Modeling epidemics caused by respiratory syncytial virus (RSV) Respiratory syncytial virus infection in tropical and developing countries Respiratory syncytial virus infections in infants: quantitation and duration of shedding The Tecumseh study of respiratory illness. 3. Incidence and periodicity of respiratory syncytial virus and Mycoplasma pneumoniae infections Immunity to and frequency of reinfection with respiratory syncytial virus Impact of viral respiratory diseases on infants and young children in a rural and urban area of southern West Virginia A newly discovered human pneumovirus isolated from young children with respiratory tract disease Seroprevalence of human metapneumovirus in Japan Human metapneumovirus reinfection among children in Thailand determined by ELISA using purified soluble fusion protein Characterization of human metapneumoviruses isolated from patients in North America Clinical impact of human metapneumovirus genotypes and genotype-specific seroprevalence in Yamagata, Japan Experimental infection of macaques with human metapneumovirus induces transient protective immunity Human metapneumovirus subgroup changes and seasonality during epidemics The time course of the immune response to experimental coronavirus infection of man Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya Coronavirus protective immunity is short-lasting. medRxiv Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period Pattern of early human-to-human transmission of Wuhan Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study A Case Series of Recurrent Viral RNA Positivity in Recovered COVID-19 Chinese Patients COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing Determination of the relative economic impact of different molecular-based laboratory algorithms for respiratory viral pathogen detection, including Pandemic (H1N1), using a secure web based platform First principles modeling of nonlinear incidence rates in seasonal epidemics A. Using fitted parameters from the data for Edmonton, Canada, and after allowing the model to stabilize (50 years run-in time), the proportion of infected (I) and resistant (R) individuals displayed a biennial pattern, shown over 10 years. B, C, and D. The R time series plotted vertically over two years (B) and the I time series plotted horizontally (C) with high (red) and low (green) prevalence years were mapped onto the I-R phase plane (D) to show the stable limit cycle with large (red) and small (green) annual loops.